| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Onconetix, Inc. | Director | Common Stock | 3.48K | $26.1K | $4.10 | Sep 26, 2024 | Direct |
| RENOVARO INC. | Interim CFO | Option to purchase shares of common stock | 58.5K | Nov 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO INC. | Nov 4, 2024 | 1 | $0 | 4 | Nov 6, 2024 | Interim CFO |
| ONCO | Onconetix, Inc. | Sep 26, 2024 | 1 | $0 | 4 | Sep 30, 2024 | Director |
| RENB | RENOVARO INC. | Mar 11, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Interim CFO |
| RENB | RENOVARO INC. | Mar 11, 2024 | 0 | $0 | 3 | Mar 13, 2024 | Interim CFO |
| BWV | Blue Water Biotech, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 1, 2023 | Director |
| BWV | Blue Water Vaccines Inc. | Aug 22, 2022 | 1 | $0 | 4 | Aug 24, 2022 | Director |
| BWV | Blue Water Vaccines Inc. | Aug 22, 2022 | 0 | $0 | 3 | Aug 24, 2022 | Director |